Our collection of research that may be useful knowledge to you


Research on
coeliac disease

Research projects in the area of coeliac disease have increased significantly in the last ten years, largely thanks to the efforts of our larger and more established Member societies. Medical experts in the fields of gastroenterology, immunology and genetics have been funded to research various aspects of coeliac disease, such as less invasive diagnosis, treatment or cure and psychological and economic burden on coeliac patients.

Scientific eBooks -
abstracts of research on coeliac disease

Our members, the National Coeliac Societies, are conducting and sponsoring research about coeliac disease in their respective countries. Since two years AOECS are collecting this, other research and innovations in coeliac disease into easy-to-read abstracts which we publish in our Scientific Research eBook.


AOECS Scientific Book 2023

This is the second collection of public scientific posters collected by AOECS. They were initially displayed during the 35th AOECS General Assembly held in November 2023, in Athens, Greece.

The posters were collected from different countries and they cover a diverse range of scientific research and innovation topics which say a lot about what is going on in research related to coeliac disease in Europe and beyond

Click on the link below to download and read the eBook.


AOECS Scientific Book 2022

The first collection of public scientific posters collected by AOECS. The abstracts were initially displayed as posters during the 34th AOECS General Assembly held in September 2022, in Lisbon, Portugal.

The aim with this collection is to spread the word and incentivize research and innovation related to coeliac disease. For this first edition, AOECS received 7 scientific abstracts which we made available to the public in this e-book.

Click on the link below to download and read the eBook.

Other research



The objective of this EU-funded project was to obtain an instrument that will be a low-cost non-invasive intelligent diagnosis system that can be present at point of care, such as a doctor’s surgery which will bring benefits to patients and healthcare professionals.

The applications of the proposed integrated micro system and its individual modules for coeliac disease diagnosis, monitoring and management are multiple. The analysis of the HLA-DQ2 & 8 genes will provide information on the genetic predisposition of an individual, while serum IgA and IgG indicate antibodies associated with gluten in the diet.


Prevent CD

The project was a European multicentre study funded by a grant from the European Union (FP6-2005-FOOD-4B-36383). The study involved 17 partners of 11 countries: 13 clinical centres, 3 industrial companies and AOECS, the representative of coeliac patients.

The study investigated the influence of infant feeding on the risk of developing CD. The hypothesis is that by exposing infants to small quantities of gluten while they are still being breast-fed to possibly induce tolerance to gluten thus reducing the risk for CD in genetically susceptible individuals.


Prospective Celiac Disease Diagnostic Evaluation

The reference standard for the diagnosis of Celiac Disease (CD) is based on estimates using mostly retrospective evaluations or data from single-center studies. Therefore, the working group of ESPGHAN on the diagnostic criteria of CD felt obliged to evaluate the new criteria on a large paediatric population in different countries and settings including a broad range of symptomatic and asymptomatic children which are referred for further work up because of a positive test result for antibodies against tissue transglutaminase. The ProCeDE study aims to provide prospective data to assure that this diagnostic procedure is valid also in clinical practice with positive predictive value above 99%. Furthermore, interobserver variability for histology and inter-test variability will be assessed and the impact of HLA-typing on diagnosis will be evaluated.



This is an article titled Determination of Gliadin as a Measure of Gluten in Food by R5 sandwich ELISA RIDASCREEN® 

Background: According to Codex Alimentarius, food products containing less than 20 mg/kg gluten, can be labeled as "gluten-free". Since 2002, the R5 antibody method allowed the determination of gluten levels and led to a huge improvement of products available to CD patients.

Research Papers

The National Center for Biotechnology Information (NCBI) is an excellent source for research papers on coeliac disease and other associated conditions.